Serina Therapeutics
SER
Serina Therapeutics (SER) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BTIG | Initiated Coverage | Buy | $8.00 | Jul 1, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Aug 28, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $15.00 | Jul 14, 2025 |
| Jones Trading | Initiated Coverage | Buy | $11.00 | Mar 11, 2025 |
Frequently asked questions
What is the latest analyst rating on SER?
On Jul 1, 2026, BTIG initiated coverage of Serina Therapeutics at Buy with a price target of $8.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.